Winslow Evans & Crocker’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$7K Sell
202
-191
-49% -$5.38K ﹤0.01% 1010
2020
Q3
$7K Hold
393
﹤0.01% 807
2020
Q2
$6K Sell
393
-1
-0.3% -$15 ﹤0.01% 830
2020
Q1
$6K Hold
394
﹤0.01% 787
2019
Q4
$10K Hold
394
﹤0.01% 806
2019
Q3
$10K Hold
394
﹤0.01% 789
2019
Q2
$12K Hold
394
﹤0.01% 757
2019
Q1
$8K Hold
394
﹤0.01% 843
2018
Q4
$8K Sell
394
-508
-56% -$13.1K ﹤0.01% 792
2018
Q3
$38K Sell
902
-428
-32% -$19.3K 0.01% 531
2018
Q2
$68K Sell
1,330
-276
-17% -$15.7K 0.02% 439
2018
Q1
$95.9K Sell
1,606
-14
-0.9% -$934 0.03% 361
2017
Q4
$127K Hold
1,620
0.04% 326
2017
Q3
$136K Hold
1,620
0.05% 305
2017
Q2
$106K Sell
1,620
-284
-15% -$19.3K 0.03% 425
2017
Q1
$138K Sell
1,904
-166
-8% -$10.9K 0.04% 353
2016
Q4
$121K Buy
+2,070
New +$109K 0.04% 373

Other funds holding ADNT

Winslow Evans & Crocker's ADNT Position: Q4 2020 in Review

Winslow Evans & Crocker reduced its Adient (ADNT) stake by 49% in Q4 2020, selling an estimated $5.38K and leaving 202 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

Winslow Evans & Crocker first reported a position in ADNT in Q4 2016 and has held it in 17 quarters since. The position peaked at $138K in Q1 2017. 299 funds tracked by Wall St. Rank hold ADNT as of Q4 2020.

  • Winslow Evans & Crocker held 202 shares of Adient worth $7K as of Q4 2020.
  • Winslow Evans & Crocker sold 191 Adient shares in Q4 2020, an estimated $5.38K.
  • Adient made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1010 holding.
  • Winslow Evans & Crocker first reported a position in Adient in Q4 2016 and has held it in 17 quarters since.
  • Winslow Evans & Crocker's Adient position peaked at $138K in Q1 2017.
  • 299 funds tracked by Wall St. Rank held Adient as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.